An analysis of data from more than 900 patients who underwent surgery for renal cell carcinoma showed that statin use was associated with a lower risk of cancer progression and death. Nearly four years after surgery, 10% of statin users died of kidney cancer compared with 17% of nonusers, researchers found. The findings were reported at the annual meeting of the American Urological Association.
Statins may lower mortality risk in kidney cancer patients
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||